LEXINGTON, Mass.--(BUSINESS WIRE)--Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will present a corporate overview at the following upcoming investor conferences:
- Jefferies Autumn 2015 Global Healthcare Conference on Wednesday, November 18, 2015 at 5:20 p.m. GMT in London.
- Stifel 2015 Healthcare Conference on Wednesday, November 18, 2015 at 3:45 p.m. EST in New York City.
In addition, Concert will be participating at the following healthcare and industry conferences:
- Brean 2015 Life Sciences Summit on November 16, 2015 in New York City.
- 10th Annual Therapeutics Area Partnerships’ Orphan Drug Track on November 19, 2015 in Boston.
- Guggenheim Securities 3rd Annual Healthcare Conference 2015 on December 15, 2015 in Boston.
Live webcasts of Concert’s presentations at the Jefferies and Stifel conferences may be accessed in the Investors section of the Company’s website at www.concertpharma.com. Please log on to the Concert website approximately 15 minutes prior to the scheduled webcast to ensure adequate time for any software downloads that may be required. A replay of each webcast will be available on Concert’s website for 2 weeks.
Concert Pharmaceuticals is a clinical stage biopharmaceutical company focused on applying its DCE Platform® (deuterated chemical entity platform) to create novel small molecule drugs. This approach starts with approved drugs, advanced clinical candidates or previously studied compounds that have the potential to be improved with deuterium substitution to enhance clinical safety, tolerability and efficacy. The Company is developing a broad pipeline targeting CNS disorders, genetic diseases, renal disease, inflammatory diseases and cancer. For more information, please visit www.concertpharma.com.
Concert Pharmaceuticals Inc., the CoNCERT Pharmaceuticals Inc. logo and DCE Platform are registered trademarks of Concert Pharmaceuticals, Inc.
